The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosis

Coronary Artery Disease

Volumn 11, Issue 6, 2000, Pages 473-479

  Carter, Andrew J ^a   Bailey, Lynn ^a   Devries, Jennifer ^a   Hubbard, Brad ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Diabetes; Restenosis; Stents

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; STREPTOZOCIN DIABETES; SWINE; THROMBOGENESIS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY DISEASE; CORONARY THROMBOSIS; CORONARY VESSELS; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; MALE; RANDOM ALLOCATION; RECURRENCE; REGRESSION ANALYSIS; STENTS; STREPTOZOCIN; SWINE; TUNICA INTIMA;

EID: 0033841997     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200009000-00005     Document Type: Article

References (30)

1. Predictive factors of restenosis after coronary stent placement
2. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement
3. Problem of angioplasty in diabetics
4. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The bypass angioplasty revascularization investigation (BARI)
5. Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization
6. Coronary stenting with a novel stainless steel balloon expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model
7. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil
8. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
9. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: A serial intravascular ultrasound study
10. Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries
11. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
12. Experimental models of coronary restenosis
13. Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis
14. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model
15. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries
16. Decreased myocardial glucose uptake during ischemia in diabetic swine
17. Induction of chronic diabetes by streptozotocin in the miniature pig
18. Diabetes mellitus and clinical and angiographic outcome after coronary stent placement
19. Potential mechanisms promoting restenosis in diabetic patients
20. Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: Evidence for a prothrombotic state
21. Continued platelet interaction with de-endothelialized aortae associated with slower re-endothelialization and more extensive intimal hyperplasia in spontaneous diabetic BB Wistar rats
22. Microvascular anastomotic thrombosis in experimental diabetes mellitus
23. De-endothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Correlation of uptake of fibrinogen and antithrombin III with thrombin generation by the exposed subendothelium
24. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
25. Pathology of acute and chronic coronary stenting in humans
26. Marked benefit of patients treated with stent and abciximab combination: 6 month outcome of the EPISTENT trial
27. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus
28. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
29. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
30. Stent design influences remodeling and neointimal formation in small diameter arteries